Is Canopy Growth Corp (TSX:WEED) Stock a Buy Below $50?

Canopy Growth Corp (TSX:WEED)(NYSE:CGC) is down significantly in the past two weeks. Should you buy now?

| More on:

The pullback in the share prices of Canadian marijuana stocks is giving some recent investors bad dreams.

Those who sat on the sidelines and missed the rally in the past year, however, are looking at the dip in the top cannabis companies and wondering which pot stocks might be attractive picks.

Let’s take a look at Canopy Growth (TSX:WEED)(NYSE:CGC) to see if it deserves to be in your portfolio today.

Perspective

At the time of writing, Canopy Growth trades for $47 per share. That’s down significantly from the $73 it fetched two weeks ago, but still well ahead of the $15 investors paid to get a piece of the company at this time last year.

What price is right?

Based on the company’s annualized revenue of just over $100 million, and that fact that it still isn’t profitable, the current market capitalization of about $11 billion seems extremely high. In fact, based on any traditional metric used to determine the value of a company, Canopy Growth, along with its peers in the cannabis sector, all trade at scary levels.

The challenge for investors is to determine what the Canadian and global cannabis markets will look like in the coming years and decide how much upfront value they want to place on that potential.

Big companies are facing the same dilemma. Last fall, Constellation Brands paid $245 million to acquire a 9.9% stake in Canopy Growth. In August, the beverage giant dropped another $5 billion to take that position to 38% by buying 104.5 million shares. The August investment put the price of Canopy Growth’s stock at about $48.60 per share, which is pretty close to where it trades today. When the deal was announced, the investment represented a 51% premium to where the stock traded the previous day.

If you think the management team at Constellation Brands knows what they are doing, the current price might be a reasonable entry point.

Should you buy?

Canopy Growth is widely viewed as one of the stocks that will emerge as a global winner in the growing medical cannabis market and is positioned well to take a good chunk of the recreational market in Canada due to its size, scale, brand recognition, and key partnerships.

If you can handle the volatility and think the cannabis market will grow as anticipated, Canopy Growth deserves to be on your radar. That said, I would keep any new investment small at this point, even after the big pullback.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Andrew Walker has no position in any stock mentioned.

More on Investing

Canada national flag waving in wind on clear day
Tech Stocks

Trump Trade: Canadian Stocks to Watch

With Trump returning to the presidency, there are some sectors that could boom in Canada, and others to watch. But…

Read more »

A train passes Morant's curve in Banff National Park in the Canadian Rockies.
Investing

Is Canadian National Railway Worth Buying for its 2.2% Dividend Yield?

Let's dive into whether Canadian National Railway (TSX:CNR) is a top buy for long-term investors at this point in the…

Read more »

nuclear power plant
Energy Stocks

Is Cameco Stock Still a Buy?

Cameco stock recently reported earnings that showed the Westinghouse investment is creating some major costs. But that could change.

Read more »

cloud computing
Dividend Stocks

Insurance Showdown: Better Buy, Great-West Life or Manulife Stock?

GWO stock and MFC stock are two of the top names in insurance, but which holds the better outlook?

Read more »

analyze data
Dividend Stocks

Here’s Why the Average TFSA for Canadians Aged 41 Isn’t Enough

The average TFSA simply isn't enough for most Canadians in their early 40s. Here's how to catch up.

Read more »

A plant grows from coins.
Dividend Stocks

The Smartest Dividend-Growth Stocks to Buy With $1,000 Right Now

New dividend-growth investors should consider CN Rail (TSX:CNR) stock and another top play if they're looking to build wealth over…

Read more »

concept of real estate evaluation
Dividend Stocks

How to Earn a TFSA Paycheque Every Month and Pay No Taxes on It

Canadian REITs can turn your TFSA into a monthly paycheque machine for life. Here's how Morguard North American Residential REIT…

Read more »

Start line on the highway
Investing

2 No-Brainer Growth Stocks to Buy Now With $5,000 and Hold Long Term

Market conditions today are ideal for growth investing, and two rising stocks are no-brainer buys in November.

Read more »